Seminars in Nuclear Medicine

Papers
(The TQCC of Seminars in Nuclear Medicine is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Letter from the Editors212
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques147
Non-FDG hypoxia tracers88
PET/CT in the Imaging of CNS Tumors87
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update87
The Value of FDG PET/CT in Penile Cancer: An Update83
New Promising Targets for Imaging in Cardiovascular Diseases65
Imaging of Invasive Fungal Infections- The Role of PET/CT60
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies57
FAPI-PET in Cardiovascular Disease50
Sentinel Lymph Node Methods in Breast Cancer49
Autoimmune Thyroid Diseases48
Theranostics in Lung Neuroendocrine Tumors48
New targets of PET imaging for renal cancer46
Letter from the Editors45
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer43
Imaging for Radiation Planning in Breast Cancer42
CD70-Targeted Radiotheranostics: Now and Future38
Artificial Intelligence for Drug Discovery: An Update and Future Prospects38
The Role of Nuclear Medicine in Benign Thyroid Disease37
Prognostic Value of PSMA PET/CT in Prostate Cancer36
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled36
Molecular Imaging in Inflammatory Bowel Disease35
PET/CT Normal Variants and Pitfalls in Paediatric Disorders35
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects34
Total-Body PET/CT: A Role of Artificial Intelligence?34
PET-CT radiomics for immunotherapy response33
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity33
The evolving role of nuclear medicine in osteomyelitis: A narrative review of current evidence and future horizons31
Imaging trends in diabetic foot infections31
Global experience in brain amyloid imaging31
The Evolution of Artificial Intelligence in Nuclear Medicine30
Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer29
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma28
FDG PET for cardiac sarcoidosis: Protocol optimization, quantification, pitfalls, and multimodality imaging integration27
The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects27
New Approaches for Imaging Bacteria27
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects26
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I26
Use of Radionuclide-Based Imaging Methods in Breast Cancer25
Renography: Methods and Pitfalls25
Expanding Role for Gallium-68 PET Imaging in Oncology25
Letter From the Editors25
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis25
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology25
Standardized PSMA-PET Imaging of Advanced Prostate Cancer24
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine24
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices24
Practical approach to diuretic renography in children: Techniques, interpretation, and pitfalls23
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases23
18F-Fluoride PET/CT—Updates23
The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma23
Update on Pediatric Nuclear Medicine in Acute Care23
Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging23
FDG PET/CT for Staging Lung Carcinoma: An Update22
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review22
Nuclear Medicine Preclinical Research: The Role of Cell Cultures22
Therapy strategies to defeat prostate cancer heterogeneity22
Functional Imaging of Testicular Torsion21
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview21
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine21
Radiolabeled Somatostatin Analogs for Cancer Imaging21
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?21
Letter from the Editors20
Targeted Radiopharmaceutical Therapy for Bone Metastases20
The Clinical Utility of Molecular Imaging in COVID-19: An Update20
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends20
The role of nuclear medicine in abdominopelvic infections19
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?19
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET18
Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma18
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma18
Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature18
Sentinel Node Mapping in Penile Cancer: An Update on Methods and Pitfalls18
Artificial Intelligence Augmented Cerebral Nuclear Imaging18
Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-517
Artificial Intelligence and Workforce Diversity in Nuclear Medicine17
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)17
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace17
Nuclear medicine in paediatric tumours: current status and focus on theranostics.17
Prostate Cancer Theranostics With 177Lu-PSMA16
RETRACTED: Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine16
Letter From the Guest Editors16
A Role of Non-FDG Tracers in Lung Cancer?16
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides16
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma16
Expanding Horizons: The Role of Kaleidoscope and Relevant Images in Seminars in Nuclear Medicine15
Cardiac PET/MRI: Recent Developments and Future Aspects15
The role of cardiac PET imaging in cardiac amyloidosis15
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging15
Neuroimaging of Mild Traumatic Injury15
Current Developments on [18F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System15
Advances and challenges of PET imaging in bladder cancer–An update and future trends15
0.06548285484314